Views:16 Author:Site Editor Publish Time: 2015-11-03 Origin:Site
CPhI & P-MEC China 2015
Add：Shanghai Pudong New International Expo Center
High-profile & ldquo; 15th World Pharmaceutical Raw Materials China Exhibition & rdquo; and & ldquo; 2015 World Pharmaceutical Contract Customization Service China Exhibition & rdquo; (CPhI, ICSE & BioPh China 2015) and & ldquo; 10th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition & rdquo; and & ldquo; 2015 World Biochemical, Analytical Instruments and Laboratory Equipment China Exhibition & rdquo; (P-MEC, InnoPack & LABC World Hina 2015) Prepared for 23 June 2015 at the New International Expo Center. The exhibition was sponsored by UBM EMEA and CCCMHPIE, and co-sponsored by UBM Sinoexpo. CPhI Shanghai has steadily passed its fifteenth year since its introduction into China in 2001.
The scene of the exhibition was full of people.
Sheng Zhou group
Shengzhou Group has four factories in Taiwan, Suzhou, Kunshan and Hefei. They manufacture rubber pistons, medical rubber plugs and medical plastic products. They are mainly supplied to large-brand pharmaceutical factories at home and abroad. At present, their customers are all over the United Kingdom, Europe and America, Japan and Korea, Southeast Asia, Pakistan, Egypt, South America and so on. The group company has more than 40 years to date. Aiming at medical grade rubber products, it is committed to become a famous solution expert for medical packaging materials in Asia. In recent years, it has actively participated in relevant pharmaceutical exhibitions, CPhI Shanghai and other pharmaceutical exhibitions in order to improve its popularity and expand customers in more countries. We sincerely welcome you to come to my booth to know Shengzhou and understand medical rubber products.
We are willing to cooperate with you and live together.
As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.
国内外丁基橡胶塞行业的研发最新进展主要有以下几方面： 1．超洁净橡胶、专用材料及配方和工艺的研究。这些研究主要是保证满足某些特殊敏感药品，如部分化学和生物活性敏感的头孢粉针制剂、酸碱性较强的输液制剂以及成分复杂的中药制剂的质量要求。从丁基橡胶塞的配方来看，生胶及一部分辅料属于脂溶性物质，其中也可能含有低分子物质，如果这些物质在生产胶塞过程中残留较多，封装药品后，就可能进入药品并发生物理吸附，导致水溶性药物的溶解性下降，出现澄清度下降甚至浑浊。所以选择超洁净的橡胶以及简单洁净的硫化系统，采用稳定有效的生产设备和工艺，从而生产出符合更多药物要求的洁净胶塞。 2．覆膜、镀膜或涂膜胶塞研究是指在胶
覆膜胶塞膜材的安全特性概况时间：2014-11-25 15:55:24来源：中国医药包装协会 [中国]自2005年淘汰天然胶塞至今将近10年，中国的药用胶塞行业有了长足的发展，为医药工业做出了应有的贡献。药用胶塞类产品品种上也发生了很大变化，从最初的卤化丁基胶塞到现在的覆膜胶塞。虽然中国药用胶塞，特别是覆膜胶塞在近年来取得很大发展，但在实际的生产、申报及使用时，仍面临一些实际困难。为了能在满足胶塞和覆膜膜材安全性的基础上，使得覆膜胶塞品种得到健康的发展，以满足国内药品市场的实际需求，现将覆膜胶塞的应用情况及其膜材的安全特性进行概括。 一、覆膜胶塞的概念覆膜胶塞是指在胶塞（裸塞）与药物接触面的局